Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Nippon Shinyaku
Nippon Shinyaku
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Viltepso
Viltolarsen
2020-08-12
2031
Duchenne muscular dystrophy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Viltolarsen
duchenne muscular dystrophy
,
muscular dystrophies
Aglatimagene besadenovec
prostatic neoplasms
,
neoplasms
Ademetionine
atopic dermatitis
,
dermatitis
,
gastroparesis
,
schizophrenia
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
traumatic brain injuries
,
brain injuries
,
aggression
,
bipolar disorder
,
psychomotor agitation
,
mania
,
kidney diseases
,
polycystic kidney diseases
,
autosomal dominant polycystic kidney
,
arthrogryposis
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
alzheimer disease
,
dementia
,
depression
,
major depressive disorder
,
depressive disorder
,
inappropriate adh syndrome
,
hyponatremia
Sodium chloride
healthy volunteers/patients
,
atherosclerosis
,
infections
,
hepatitis b
,
chronic hepatitis b
,
communicable diseases
,
virus diseases
,
hepatitis
,
herpesviridae infections
,
hepatitis a
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
hemorrhage
,
subarachnoid hemorrhage
,
malignant mesothelioma
,
mesothelioma
,
non-hodgkin lymphoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
colorectal neoplasms
,
uterine cervical neoplasms
,
covid-19
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
carcinoma
,
transitional cell carcinoma
,
multiple sclerosis
,
sclerosis
,
rheumatoid arthritis
,
arthritis
,
relapsing-remitting multiple sclerosis
,
recurrence
,
chronic progressive multiple sclerosis
,
ulcerative colitis
,
colitis
,
ulcer
,
osteoarthritis
,
pleural empyema
,
empyema
,
graft rejection
,
giant cell arteritis
,
polymyalgia rheumatica
,
kidney transplantation
,
heart failure
,
drug-related side effects and adverse reactions
,
renal insufficiency
,
thrombosis
,
hiv infections
,
osteoporosis
,
hip fractures
,
bone fractures
,
hypertension
,
cardiovascular diseases
,
health risk behaviors
,
vascular stiffness
Sodium lactate
uterine hemorrhage
,
dysmenorrhea
,
contraception
,
osteoporosis
,
postmenopause
,
atopic dermatitis
,
eczema
,
skin diseases
,
dermatitis
,
eczematous skin diseases
,
hemorrhage
,
metrorrhagia
ILGINATINIB
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
Microcrystalline cellulose
uterine hemorrhage
,
dysmenorrhea
,
contraception
,
osteoporosis
,
postmenopause
,
atopic dermatitis
,
eczema
,
skin diseases
,
dermatitis
,
eczematous skin diseases
,
hemorrhage
,
metrorrhagia
NS-018
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use